Tissue Plasminogen Activator Promotes Matrix Metalloproteinase-9 Upregulation After Focal Cerebral Ischemia

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Stroke

• Publication date

  2005-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000177517.01203.ebPMID 16051896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• tPA and proteolysis in the neurovascular unit.

  2004cited by this paper
• In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone.

  2004cited by this paper
• Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke

  2004cited by this paper
• Equivocal roles of tissue-type plasminogen activator in stroke-induced injury.

  2004cited by this paper
• Evidence of Reperfusion Injury, Exacerbated by Thrombolytic Therapy, in Human Focal Brain Ischemia Using a Novel Imaging Marker of Early Blood–Brain Barrier Disruption

  2004cited by this paper
• Early blood–brain barrier disruption in human focal brain ischemia

  2004cited by this paper
• Arginine 260 of the Amino-terminal Domain of NR1 Subunit Is Critical for Tissue-type Plasminogen Activator-mediated Enhancement of N-Methyl-D-aspartate Receptor Signaling*

  2004cited by this paper
• Poultry Genetic Resources--Operation Rescue Needed

  2003cited by this paper
• Tissue inhibitor of metalloproteinases‐3 and matrix metalloproteinase‐3 regulate neuronal sensitivity to doxorubicin‐induced apoptosis

  2003cited by this paper
• Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Neurological diseases: Mechanisms, challenges and opportunities in stroke

  2003cited by this paper
• Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke

  2003cited by this paper
• Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases

  2003cited by this paper
• Stroke--tPA and the Clinic

  2003cited by this paper
• Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator

  2003cited by this paper
• Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

  2003cited by this paper
• Cerebral Microvessel Responses to Focal Ischemia

  2003cited by this paper
• Thrombolytic Therapy With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke: Where Do We Go From Here? A Cumulative Meta-Analysis

  2003cited by this paper
• An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice

  2003cited by this paper
• Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.

  2003cited by this paper
• Rosenberg GA. Matrix metalloproteinases in neuroinflammation. GLIA 2002;39(3):279–291.

  2002cited by this paper
• Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats

  2002cited by this paper
• Tissue Plasminogen Activator Mediates Microglial Activation via Its Finger Domain through Annexin II

  2002cited by this paper
• Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion Injury: Mechanical Versus Embolic Focal Ischemia in Spontaneously Hypertensive Rats

  2002cited by this paper
• Microplasmin: A Novel Thrombolytic That Improves Behavioral Outcome After Embolic Strokes in Rabbits

  2002cited by this paper
• Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases

  2002cited by this paper
• Matrix metalloproteinases in neuroinflammation

  2002cited by this paper
• Reciprocal actions of NCAM and tPA via a Ras-dependent MAPK activation in rat hippocampal neurons.

  2002cited by this paper
• Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation.

  2002cited by this paper
• LRP: a multifunctional scavenger and signaling receptor.

  2001cited by this paper
• Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia

  2001cited by this paper
• Metalloproteinases in biology and pathology of the nervous system

  2001cited by this paper
• Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia

  2001cited by this paper
• Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94

  2000cited by this paper
• Thrombolysis in acute ischemic stroke: controlled trials and clinical experience.

  1999cited by this paper
• CACNA1A mutations

  1999cited by this paper
• The Pupil

  1993cited by this paper
• Ischemic Brain Edema and the Osmotic Gradient between Blood and Brain

  1988cited by this paper

• Roles of tissue plasminogen activator in chronic subdural hematoma, independent of the fibrinolytic system

  2026influential citation
• Tissue-type plasminogen activator expression by endothelial cells and oligodendrocytes is required for proper CNS myelination

  2025cites this paper
• Dl-3-n-butylphthalide reduces urokinase-induced hemorrhagic transformation after stroke by targeting NET-mediated microglial activation.

  2025cites this paper
• Multifunctionality of tissue inhibitor of metalloproteinase-1 in central nervous system diseases.

  2025cites this paper
• The Role of Blood–Brain Barrier Disruption in Epilepsy: Mechanisms and Consequences

  2025cites this paper
• Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy

  2024cites this paper
• LOX-1 and MMP-9 inhibition attenuates the detrimental effects of delayed rt-PA therapy and improves outcomes after acute ischemic stroke

  2023cites this paper
• Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk

  2023cites this paper
• The role and mechanisms of microvascular damage in the ischemic myocardium

  2023cites this paper
• Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke

  2023cites this paper
• Dynamic regulation of the extracellular matrix in reward memory processes: a question of time

  2023cites this paper
• Transient plasticity response is regulated by histone deacetylase inhibitor in oxygen–glucose deprivation condition

  2023cites this paper
• The Critical Role of Equilibrative Nucleoside Transporter-2 in Modulating Cerebral Damage and Vascular Dysfunction in Mice with Brain Ischemia-Reperfusion

  2023cites this paper
• Therapeutical Significance of Serpina3n Subsequent Cerebral Ischemia via Cytotoxic Granzyme B Inactivation

  2022cites this paper
• Prognostic value of serum MMP-9 level in acute ischemic stroke patient

  2022cites this paper
• Elevated plasma syndecan-1 as glycocalyx injury marker predicts unfavorable outcomes after rt-PA intravenous thrombolysis in acute ischemic stroke

  2022influential citation
• Extracellular matrix metalloproteinase-9 (MMP-9) is required in female mice for 17β-estradiol enhancement of hippocampal memory consolidation.

  2022cites this paper
• Continuous Glibenclamide Prevents Hemorrhagic Transformation in a Rodent Model of Severe Ischemia-Reperfusion.

  2021cites this paper
• Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke

  2021cites this paper
• Initial Stress Hyperglycemia Is Associated With Malignant Cerebral Edema, Hemorrhage, and Poor Functional Outcome After Mechanical Thrombectomy

  2021cites this paper
• Interferon-β alleviates delayed tPA-induced adverse effects via modulation of MMP3/9 production in ischemic stroke.

  2020cites this paper
• The blood brain barrier in cerebral ischemic injury – Disruption and repair

  2020cites this paper
• Temperature-Induced Changes in Reperfused Stroke: Inflammatory and Thrombolytic Biomarkers

  2020cites this paper
• Prothymosin alpha and its mimetic hexapeptide improve delayed tissue plasminogen activator‐induced brain damage following cerebral ischemia

  2020cites this paper
• Diabetes mellitus: A common comorbidity increasing hemorrhagic transformation after tPA thrombolytic therapy for ischemic stroke

  2020cites this paper
• Structural and Functional Remodeling of the Brain Vasculature Following Stroke

  2020cites this paper
• Novel approaches for the delivery of therapeutics in ischemic stroke.

  2020cites this paper
• Tranexamic Acid Improves Memory and Learning Abilities in Aging Mice

  2020cites this paper
• Association of Matrix Metalloproteinase 9 and Cellular Fibronectin and Outcome in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

  2020cites this paper
• Haplotype analysis of SERPINE1 gene: Risk for aneurysmal subarachnoid hemorrhage and clinical outcomes

  2019cites this paper
• Matrix metalloproteinase-9 and p53 involved in chronic fluorosis induced blood-brain barrier damage and neurocyte changes

  2019cites this paper
• Effect of tranexamic acid in improving the lifespan of naturally aging mice

  2019cites this paper
• Neutrophils in tPA‐induced hemorrhagic transformations: Main culprit, accomplice or innocent bystander?

  2019cites this paper
• tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?

  2019cites this paper
• Matrix metalloproteinases and ADAMs in stroke

  2019cites this paper
• Role of Matrix Metalloproteinase-9 in Neonatal Hypoxic-Ischemic Encephalopathy

  2019cites this paper
• Glycyrrhizin Prevents Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke with Delayed Thrombolysis Through Targeting Peroxynitrite-Mediated HMGB1 Signaling

  2019cites this paper
• Extracellular Matrix Signaling Through β3 Integrin Mediates Cocaine Cue-Induced Transient Synaptic Plasticity and Relapse.

  2019influential citation
• Magnesium sulfate protects blood–brain barrier integrity and reduces brain edema after acute ischemic stroke in rats

  2019cites this paper
• The role of endogenous tissue-type plasminogen activator in neuronal survival after ischemic stroke: friend or foe?

  2019cites this paper
• Preischemic treadmill exercise improves short-term memory by inhibiting hypoperfusion-induced disruption of blood-brain barrier after bilateral common carotid arteries occlusion

  2019cites this paper
• Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.

  2018cites this paper
• Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice

  2018cites this paper
• Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury

  2018cites this paper
• Basement membrane and stroke

  2018cites this paper
• Thrombolysis is an Independent Risk Factor for Poor Outcome After Carotid Revascularization

  2018cites this paper
• Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non‐mucosal venous injury model in haemophilic rodents

  2018cites this paper
• Gelatinase-Mediated Impairment of Microvascular Beds in Cerebral Ischemia and Reperfusion Injury

  2018cites this paper
• Sur1–Trpm4-Promising Target for Brain Edema Treatment in Brain Edema: From Molecular Mechanisms to Clinical Practice

  2017cites this paper
• Blood–Brain Barrier: Genomics, Proteomics, Disease Targets, and Drug Delivery

  2017cites this paper
• Protective effects of angiopoietin-like 4 on the blood-brain barrier in acute ischemic stroke treated with thrombolysis in mice.

  2017cites this paper
• Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.

  2017cites this paper
• Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke

  2017cites this paper
• Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke

  2017cites this paper
• Prediction Of Adverse Outcomes After Rt-Pa Treatment In Ischemic Stroke Patients

  2017cites this paper
• Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats

  2017cites this paper
• Protease-Activated Receptor-1 Supports Locomotor Recovery by Biased Agonist Activated Protein C after Contusive Spinal Cord Injury

  2017cites this paper
• Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.

  2016cites this paper
• Inflammatory Disequilibrium in Stroke.

  2016cites this paper
• Characterization of secretomes from a human blood brain barrier endothelial cells in-vitro model after ischemia by stable isotope labeling with aminoacids in cell culture (SILAC).

  2016cites this paper
• Too good to treat? ischemic stroke patients with small computed tomography perfusion lesions may not benefit from thrombolysis

  2016cites this paper
• Targeting ONOO-/HMGB1/MMP-9 Signaling Cascades: Potential for Drug Development from Chinese Medicine to Attenuate Ischemic Brain Injury and Hemorrhagic Transformation Induced by Thrombolytic Treatment

  2016cites this paper
• Influence of ApoE on LRP1 Function and Amyloid Transport Across the Blood-Brain Barrier

  2016cites this paper
• Analysis of Recurrent Stroke Volume Between VKA (Vitamin K Antagonist) and Three NOACs (Non-Vitamin K Antagonist Oral Anticoagulants) Under Oral Anticoagulant Therapy

  2016cites this paper
• Plasma First Resuscitation Reduces Lactate Acidosis, Enhances Redox Homeostasis, Amino Acid and Purine Catabolism in a Rat Model of Profound Hemorrhagic Shock

  2016cites this paper
• Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives.

  2016cites this paper
• Too good to treat? Ischemic stroke patients with small CT perfusion lesions may not benefit from thrombolysis

  2016cites this paper
• TURN Score Predicts 24-Hour Cerebral Edema After IV Thrombolysis

  2016cites this paper
• Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis

  2016cites this paper
• Blood – Brain Barrier : Immunologic Barrier and Dysfunction With Stroke

  2016cites this paper
• Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke

  2016cites this paper
• High-resolution MRI: detection of a culprit plaque after recurrent thrombolysis

  2015cites this paper
• Anti‐tissue Plasminogen Activator (tPA) as an Effective Therapy of Neonatal Hypoxia–Ischemia with and without Inflammation

  2015cites this paper
• Peroxynitrite Decomposition Catalyst Reduces Delayed Thrombolysis‐induced Hemorrhagic Transformation in Ischemia‐reperfused Rat Brains

  2015cites this paper
• Alterations of the Blood-Brain Barrier in Post-Traumatic Epilepsy

  2015cites this paper
• Caveolin‐1 mediates tissue plasminogen activator‐induced MMP‐9 up‐regulation in cultured brain microvascular endothelial cells

  2015cites this paper
• Novel therapeutic and modeling approaches to experimental intracerebral hemorrhage

  2015cites this paper
• The March of Thrombolytic Therapy for Acute Ischemic Stroke to Clinical Trials: Pre-clinical Thrombolysis and Adjuncts to Thrombolysis Research

  2015cites this paper
• The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier

  2014cites this paper
• Intravenous tissue-type plasminogen activator therapy is an independent risk factor for symptomatic intracerebral hemorrhage after carotid endarterectomy.

  2014cites this paper
• Advances and Potential New Treatments in Stroke Management

  2014cites this paper
• Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase‐2 and NAD(P)H oxidase

  2014cites this paper
• Plasmin-Dependent Modulation of the Blood–Brain Barrier: A Major Consideration during tPA-Induced Thrombolysis?

  2014cites this paper
• Beneficial effects of edaravone on the expression of serum matrix metalloproteinase-9 after cerebral hemorrhage.

  2014cites this paper
• Interactions of Oxidative Stress and Neurovascular Inflammation in the Pathogenesis of Traumatic Brain Injury

  2014cites this paper
• Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans.

  2014cites this paper
• Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke

  2014cites this paper
• Rivaroxaban and Apixaban Reduce Hemorrhagic Transformation After Thrombolysis by Protection of Neurovascular Unit in Rat

  2014cites this paper
• Evolution of Intracerebral Hemorrhage after Intravenous Tpa: Reversal of Harmful Effects with Mast Cell Stabilization

  2014cites this paper
• Critical role of matrix metalloprotease-9 in chronic high fat diet-induced cerebral vascular remodelling and increase of ischaemic brain injury in mice†.

  2014cites this paper
• Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke

  2013cites this paper
• Tissue Plasminogen Activator in Trabecular Meshwork Attenuates Steroid Induced Outflow Resistance in Mice

  2013cites this paper
• In vivo optical imaging correlates with improvement of cerebral ischemia treated by intravenous bone marrow stromal cells (BMSCs) and edaravone

  2013cites this paper
• Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke

  2013cites this paper
• Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator.

  2013cites this paper
• Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke

  2013cites this paper
• Tissue plasminogen activator deficiency promotes early phase regeneration in the olfactory epithelium after bulbectomy

  2013cites this paper
• The angiopoietin:Tie 2 interaction: a potential target for future therapies in human vascular disease.

  2013cites this paper
• Combined therapy with PJ34, a poly(ADP‐ribose)polymerase inhibitor, reduces tissue plasminogen activator‐induced hemorrhagic transformations in cerebral ischemia in mice

  2013cites this paper
• Pediatric ischemic stroke: acute management and areas of research.

  2013cites this paper